ArticleBriefings in bioinformatics2025
MegSite: an accurate nucleic acid-binding residue prediction method based on multimodal protein language model.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- QSyncFold: quantum neural network for multidimensional sync-discovery in protein folding.Briefings in bioinformatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Accurate identification of nucleic acid-binding residues is crucial for understanding protein-nucleic acid interactions, which play a key role in gene expression research and the discovery of regulatory mechanisms. Despite numerous computational efforts to address this challenge, achieving high accuracy remains difficult due to the complexity of extracting meaningful insights from proteins. Here, we introduce MegSite, a novel multimodal protein language model-informed method that integrates discriminative knowledge from protein sequence, structure, and function. This work presents the first integration of ESM3 multimodal features for nucleic acid-binding site prediction. MegSite significantly outperforms existing prediction methods, as evidenced by its performance on multiple independent test sets. The Matthews correlation coefficient values achieved by MegSite on DNA-129_Test, DNA-181_Test, RNA-117_Test, and RNA-285_Test are 0.567, 0.444, 0.411, and 0.421, representing the improvements of 2.72%, 7.66%, 1.22% and 6.58% over the second-best method separately. Notably, MegSite demonstrates robust performance even on proteins with low structural similarity, surpassing the previous structure-based methods. Furthermore, this method is seamlessly extendable to the predicted protein structure and a newly released RNA-binding residue test set with high accuracy, highlighting its broad applicability. Comprehensive experimental results reveal that the superior performance of MegSite is attributed to its effective integration of multimodal protein knowledge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.